RE:Supported devicesI see EKG once again cannot hold its gains, what is going on here, are a lot of these devices and software duplicate or very close to what other Companies already have out or what. There is definitely a problem as the market does not seem to care about what EKG has to offer thus the .075 bid and ask this morning a little increase in price to .13 after the FDA approval announcement and next day a steady decline in price. What he-l is up with that,this stock should be trading .50 plus